A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma

Christopher W. Ryan, Chacon Matias, Mark Agulnik, Antonio López–Pousa, Charles C. Williams, Dinesh P. de Alwis, Christopher Kaiser, Mary Alice Miller, S. Ermisch, Robert Ilaria,

Investigational New Drugs · 2012 · 13 citations · 21 references

Concepts

References

21